Tin tức & Cập nhật
Lọc theo Chuyên ngành:
SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes
18 May 2022
Treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) leads to lower rates of cardiovascular disease (CVD) events in patients with type 2 diabetes mellitus (T2DM) than does dipeptidyl peptidase-4 inhibitors (DPP4i), reports a recent Japan study.
SGLT2i beats DPP4i at reducing cardiovascular disease in type 2 diabetes
18 May 2022
High BMI might promote MGUS progression to multiple myeloma
17 May 2022
In individuals with monoclonal gammopathy of undetermined significance (MGUS), obesity or high body mass index (BMI) seems to aggravate the risk of disease progression to multiple myeloma (MM), an effect that appears to be stronger in women, a recent study has found.
